Detalhe da pesquisa
1.
A New Hierarchy of Research Evidence for Tumor Pathology: A Delphi Study to Define Levels of Evidence in Tumor Pathology.
Mod Pathol
; 37(1): 100357, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-37866639
2.
Investigating the Current Harmonization Status of Tumor Markers Using Global External Quality Assessment Programs: A Feasibility Study.
Clin Chem
; 70(4): 669-679, 2024 04 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-38385453
3.
Prognostic value of blood-based protein biomarkers in non-small cell lung cancer: A critical review and 2008-2022 update.
Tumour Biol
; 46(s1): S111-S161, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-37927288
4.
A pocket companion to cell-free DNA (cfDNA) preanalytics.
Tumour Biol
; 46(s1): S297-S308, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-37840517
5.
Lung cancer tumor marker analysis: A clinical laboratory perspective.
Tumour Biol
; 46(s1): S9-S14, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38517828
6.
Improvement of differential diagnosis of lung cancer by use of multiple protein tumor marker combinations.
Tumour Biol
; 46(s1): S81-S98, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38277317
7.
Lack of clinical utility of serum macrophage migration inhibitory factor (MIF) for monitoring therapy response and estimating prognosis in advanced lung cancer.
Tumour Biol
; 46(s1): S341-S353, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-37545291
8.
Lung cancer biomarkers: Raising the clinical value of the classical and the new ones.
Tumour Biol
; 46(s1): S1-S7, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38517827
9.
Serum tumor markers for response prediction and monitoring of advanced lung cancer: A review focusing on immunotherapy and targeted therapies.
Tumour Biol
; 46(s1): S233-S268, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-37248927
10.
Relevance of tumor markers for prognosis and predicting therapy response in non-small cell lung cancer patients: A CEPAC-TDM biomarker substudy.
Tumour Biol
; 46(s1): S191-S206, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38363625
11.
Missing prognostic value of soluble PD-1, PD-L1 and PD-L2 in lung cancer patients undergoing chemotherapy - A CEPAC-TDM biomarker substudy.
Tumour Biol
; 46(s1): S355-S367, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38277316
12.
Prognostic value of tumor markers ProGRP, NSE and CYFRA 21-1 in patients with small cell lung cancer and chemotherapy-induced remission.
Tumour Biol
; 46(s1): S219-S232, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-37840518
13.
Combined use of CYFRA 21-1 and CA 125 predicts survival of patients with metastatic NSCLC and stable disease in IMpower150.
Tumour Biol
; 46(s1): S177-S190, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-37545290
14.
CYFRA 21-1, CA 125 and CEA provide additional prognostic value in NSCLC patients with stable disease at first CT scan.
Tumour Biol
; 46(s1): S163-S175, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-37840516
15.
Immature Platelet Fraction Predicts Adverse Events in Patients With Acute Coronary Syndrome: the ISAR-REACT 5 Reticulated Platelet Substudy.
Arterioscler Thromb Vasc Biol
; 43(2): e83-e93, 2023 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36546322
16.
Bioactive adrenomedullin (bio-ADM) is associated with endothelial dysfunction in infants and children with complex congenital heart disease undergoing open-heart surgery on cardiopulmonary bypass.
Clin Chem Lab Med
; 62(3): 551-561, 2024 Feb 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-37870269
17.
PATHFINDER-CHD: prospective registry on adults with congenital heart disease, abnormal ventricular function, and/or heart failure as a foundation for establishing rehabilitative, prehabilitative, preventive, and health-promoting measures: rationale, aims, design and methods.
BMC Cardiovasc Disord
; 24(1): 181, 2024 Mar 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-38532336
18.
Influence of a 7-day Transalpine Trail Run on cardiac biomarkers and myocardial function.
Scand J Med Sci Sports
; 34(3): e14590, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38483076
19.
De Ritis ratio and long-term major cardiovascular adverse events in patients undergoing elective percutaneous coronary intervention.
Eur J Clin Invest
; 53(5): e13942, 2023 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-36575818
20.
CA125: a novel cardiac biomarker for infants with congenital diaphragmatic hernia.
Pediatr Res
; 93(3): 682-688, 2023 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-35705629